(S1 (S (NP (CD Two) (JJ Japanese) (NNS scientists)) (VP (VBD said) (SBAR (S (NP (PRP they)) (VP (VBD discovered) (NP (DT an) (NN antibody) (SBAR (IN that) (S (, ,) (PP (IN in) (NP (NN laboratory) (NN test-tube) (NNS experiments))) (, ,) (VP (VBZ kills) (NP (JJ AIDS-infected) (NNS cells)) (SBAR (IN while) (S (VP (VBG preserving) (NP (JJ healthy) (NNS cells))))))))))))) (. .)))

(S1 (S (SBAR (IN If) (S (NP (JJ further) (NNS experiments)) (VP (VBP are) (ADJP (JJ successful))))) (, ,) (NP (DT the) (NN work)) (VP (MD would) (VP (VB represent) (NP (NP (DT a) (JJ major) (NN advance)) (PP (IN in) (NP (NP (NN research)) (PP (IN on) (NP (VBN acquired) (JJ immune) (NN deficiency) (NN syndrome)))))))) (. .)))

(S1 (S (NP (NP (DT The) (NN drug) (NNP AZT)) (, ,) (NP (NP (DT the) (JJ only) (NN treatment)) (RRC (ADVP (RB currently)) (PP (IN on) (NP (DT the) (NN market))))) (, ,)) (VP (VBZ claims) (S (VP (ADVP (RB only)) (VP (TO to) (VP (VB help) (S (VP (VB stop) (NP (NP (DT the) (NN spread)) (PP (IN of) (NP (NNP AIDS)))))))) (, ,) (RB not) (VP (TO to) (VP (VB cure) (NP (PRP it))))))) (. .)))

(S1 (S (CC But) (NP (NP (NP (JJ several) (NNS analysts)) (CC and) (NP (JJ Japanese) (NNS scientists))) (ADJP (JJ familiar) (PP (IN with) (NP (NP (DT the) (NN study)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBD was) (VP (VBN announced) (PP (IN at) (NP (NP (DT a) (NN conference)) (PP (IN in) (NP (NNP Nagoya))))) (NP (NN yesterday)))))) (, ,))))) (VP (VBD expressed) (NP (NN skepticism)) (PP (IN over) (NP (NP (DT the) (NN significance)) (PP (IN of) (NP (DT the) (NNS results)))))) (. .)))

(S1 (S (CC And) (NP (DT the) (NNS researchers)) (ADVP (PRP themselves)) (VP (VBD acknowledged) (SBAR (S (NP (PRP they)) (ADVP (RB still)) (VP (MD must) (VP (VB do) (NP (ADJP (RB much) (JJR more)) (NN work)) (SBAR (IN before) (S (NP (PRP they)) (VP (MD can) (VP (VB say) (SBAR (IN whether) (S (NP (DT the) (NN treatment)) (VP (MD would) (ADVP (RB actually)) (VP (VB cure) (NP (NNS humans))))))))))))))) (. .)))

(S1 (S (NP (NP (NNP Shin) (NNP Yonehara)) (, ,) (NP (NP (DT a) (NN research) (NN scientist)) (PP (IN at) (NP (NP (DT the) (NNP Tokyo) (NNP Metropolitan) (NNP Institute)) (PP (IN of) (NP (NNP Medical) (NNP Science)))))) (, ,)) (VP (VBD said) (SBAR (S (NP (DT the) (NN antibody)) (NP (PRP he)) (VP (VBD discovered) (SBAR (S (VP (VBZ works) (PP (IN by) (S (VP (VBG recognizing) (NP (NP (DT an) (NN antigen)) (VP (VBN called) (S (NP (NP (DT a) (NNP Fas-antigen)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ characteristic) (PP (IN of) (NP (DT an) (JJ infected) (NN cell))))))))))))))))))))) (. .)))

(S1 (S (NP (DT The) (NN antibody)) (ADVP (RB then)) (VP (VBZ kills) (NP (DT the) (NN cell))) (. .)))

(S1 (S (NP (NP (NNP Dr.) (NNP Yonehara)) (CC and) (NP (NP (PRP$ his) (NN partner)) (, ,) (NP (NP (NNP Nobuyuki) (NNP Kobayashi)) (PP (IN of) (NP (NNP Yamaguchi) (NNP University)))) (, ,))) (VP (VBD said) (SBAR (S (NP (PRP$ their) (NNS experiments)) (VP (VBD showed) (SBAR (IN that) (S (NP (DT the) (NN antibody)) (VP (VBD wiped) (PRT (RP out)) (NP (NP (DT an) (NN average)) (PP (IN of) (NP (NP (CD 60) (NN %)) (PP (IN of) (NP (NP (JJ AIDS-infected) (NNS cells)) (PP (IN within) (NP (CD three) (NNS days))))))))))))))) (. .)))

(S1 (S (S (PP (IN In) (NP (NP (DT some)) (PP (IN of) (NP (DT the) (NNS experiments))))) (, ,) (NP (PRP it)) (VP (VBD killed) (NP (RB almost) (PDT all) (DT the) (JJ infected) (NNS cells)))) (, ,) (NP (DT the) (NNS researchers)) (VP (VBD said)) (. .)))

(S1 (S (ADVP (RB Meanwhile)) (, ,) (NP (NP (QP (JJR fewer) (IN than) (CD 10)) (NN %)) (PP (IN of) (NP (DT the) (JJ healthy) (NNS cells)))) (VP (VBD were) (VP (VBN killed))) (. .)))

(S1 (S (NP (DT The) (CD two)) (VP (VBD said) (SBAR (S (NP (PRP they)) (VP (MD must) (ADVP (RB still)) (VP (VP (VB do) (NP (JJR more) (NN laboratory) (NNS tests))) (, ,) (RB then) (VP (NN experiment) (PP (IN on) (NP (NNS animals))))))))) (. .)))

(S1 (S (NP (PRP They)) (VP (VBD said) (SBAR (S (NP (PRP they)) (VP (VBD hoped) (S (VP (TO to) (VP (VB conduct) (NP (NP (NNS tests)) (PP (IN on) (NP (NP (JJ human) (NNS patients)) (PP (IN in) (NP (DT the) (NNP U.S.)))))) (PP (IN by) (NP (RB late) (JJ next) (NN year)))))))))) (. .)))

(S1 (S (S (NP (NNP Japan)) (VP (VBZ does) (RB n't) (VP (VB have) (S (NP (JJ enough) (NNP AIDS) (NNS patients)) (VP (TO to) (VP (VB do) (NP (JJ significant) (NN experimentation)) (PP (IN in) (NP (DT that) (NN country))))))))) (, ,) (NP (PRP they)) (VP (VBD said)) (. .)))

(S1 (S (NP (DT The) (NN announcement)) (VP (VP (VBD got) (NP (JJ wide) (NN exposure)) (PP (IN in) (NP (DT the) (JJ Japanese) (NNS media)))) (, ,) (CC and) (VP (ADVP (RB even)) (VBD moved) (NP (DT some) (JJ pharmaceutical) (NNS stocks)) (NP (NN yesterday)))) (. .)))

(S1 (S (CC But) (NP (NP (NNP Takashi) (NNP Kitamura)) (, ,) (NP (NP (NP (NN director)) (PP (IN of) (NP (NP (DT the) (NN biology) (NN department)) (PP (IN at) (NP (NP (NP (NNP Japan) (POS 's)) (NNP National) (NNP Institute)) (PP (IN of) (NP (NNP Health)))))))) (CC and) (NP (NP (NN secretary)) (PP (IN of) (NP (NP (DT the) (NN government) (POS 's)) (JJ AIDS-research) (NN center))))) (, ,)) (VP (VBD said) (, ,) (`` `) (S (`` `) (NP (PRP I)) (VP (VBP 'm) (RB not) (ADJP (RB so) (JJ optimistic) (PP (IN of) (NP (NP (PRP$ its) (JJ future) (NN use)) (PP (IN in) (NP (JJ therapeutic) (NNS methods))))))))) (. .) ('' ') ('' ')))

(S1 (S (NP (PRP He)) (VP (VP (VBD said) (SBAR (S (NP (DT some) (JJ infected) (NNS cells)) (VP (MD may) (RB not) (VP (VB have) (NP (DT the) (JJ relevant) (NN antigen))))))) (CC and) (ADVP (RB so)) (VP (MD would) (RB n't) (VP (VB be) (VP (VBN killed) (PP (ADVP (RB even)) (IN after) (NP (NP (NN exposure)) (PP (TO to) (NP (DT the) (NN antibody))))))))) (. .)))

(S1 (SINV (`` `) (S (`` `) (NP (DT The) (NNS results)) (VP (VBP seem) (S (VP (TO to) (VP (VB be) (ADJP (RB very) (JJ premature)))))) (, ,) ('' ')) ('' ') (VP (VBD said)) (NP (NP (NNP Mitsuru) (NNP Miyata)) (, ,) (NP (NP (NN editor)) (PP (IN of) (NP (NP (NNP Nikkei) (NNP Biotechnology)) (, ,) (NP (DT a) (VBG leading) (JJ Japanese) (NN industry) (NN newsletter)))))) (. .)))

(S1 (S (NP (NNP Dr.) (NNP Kobayashi)) (VP (VBD responded) (SBAR (IN that) (S (NP (PRP he)) (VP (VBD thought) (SBAR (S (NP (DT the) (NN antibody)) (VP (MD could) (RB potentially) (VP (VB kill) (NP (DT all) (JJ infected) (NNS cells)))))))))) (. .)))

(S1 (S (CC But) (NP (NP (PRP he)) (CC and) (NP (NNP Dr.) (NNP Yonehara))) (VP (VBD said) (SBAR (S (NP (EX there)) (VP (VBD were) (ADVP (RB still)) (NP (NP (JJ several) (NNS uncertainties)) (, ,) (PP (ADVP (RB particularly)) (VBG regarding) (NP (JJ possible) (NN side) (NNS effects)))))))) (. .)))

(S1 (SINV (`` `) (S (`` `) (S (NP (PRP$ Our) (NN antibody)) (ADVP (RB specifically)) (VP (VBD killed) (NP (JJ infected) (NNS cells)) (PP (IN at) (NP (DT a) (ADJP (RB very) (JJ low)) (NN dose))))) (, ,) (CC but) (S (NP (PRP it)) (VP (MD can) (ADVP (RB also)) (VP (VB kill) (NP (JJ other) (NNS cells))))) (, ,) ('' ')) ('' ') (VP (VBD said)) (NP (NNP Dr.) (NNP Yonehara)) (. .)))

(S1 (S (`` `) (S (`` `) (NP (PRP We)) (VP (VBP do) (RB n't) (VP (VB know) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (PRP$ our) (NN antibody))) (PP (IN on) (NP (DT the) (JJ human) (NN body)))))) (. .) ('' ')) ('' ')))

(S1 (S (S (NP (NNP AIDS)) (VP (VBZ is) (RB n't) (VP (VBN considered) (NP (DT a) (JJ widespread) (NN problem)) (PP (IN in) (NP (NNP Japan)))))) (PRN (: --) (S (NP (DT the) (NN government)) (VP (VBZ reports) (NP (NP (QP (RB about) (CD 1,000)) (JJ known) (NNS carriers)) (PP (IN of) (NP (DT the) (NN virus)))))) (: --)) (CC but) (S (NP (JJ many) (NNS companies)) (VP (VBP have) (VP (VBN poured) (NP (JJ substantial) (NNS resources)) (PP (IN into) (NP (NN research))) (PP (IN in) (NP (JJ recent) (NNS years))) (, ,) (S (VP (VBG hoping) (S (VP (TO to) (VP (VB cash) (PRT (RP in)) (PP (IN on) (NP (DT a) (JJ possible) (NN cure))))))))))) (. .)))

(S1 (S (NP (NNP Dr.) (NNP Kitamura)) (VP (VBD said) (SBAR (SBAR (S (NP (QP (RB about) (CD 35)) (NNS projects)) (VP (VBP are) (ADVP (RB currently)) (PP (IN under) (NP (NN way))) (PP (IN in) (NP (NNP Japan)))))) (, ,) (CC and) (SBAR (IN that) (S (NP (NP (JJ Japanese) (NNS researchers)) (PP (IN in) (NP (DT the) (JJ past) (NN year)))) (VP (VBP have) (VP (VBN made) (S (ADJP (JJ available) (NP (NP (CD three) (JJ possible) (NNS cures)) (PP (TO to) (NP (NNP American) (NNS researchers)))) (PP (IN for) (NP (JJ clinical) (NNS tests))))))))))) (. .)))

(S1 (S (NP (PRP He)) (VP (VBD said) (SBAR (IN that) (S (SBAR (WHADVP (WRB when)) (S (NP (NP (NNS scientists)) (PP (IN from) (NP (DT the) (CD two) (NNS countries)))) (VP (VBP meet) (ADVP (RB again)) (PP (IN in) (NP (NNP January))) (PP (IN in) (NP (NNP New) (NNP Orleans)))))) (, ,) (NP (DT the) (NNPS Japanese)) (VP (MD will) (VP (VB present) (NP (QP (IN at) (JJS least) (CD three) (JJR more)) (NNS drugs)) (PP (IN for) (NP (JJ human) (NN testing)))))))) (. .)))

(S1 (S (NP (NNP AZT)) (VP (VBZ is) (NP (NP (NP (DT the) (NN world) (POS 's)) (JJ only) (NN prescription) (NN medicine)) (VP (VBN approved) (PP (IN for) (S (VP (VBG treating) (NP (DT the) (NN disease)))))))) (. .)))

(S1 (S (NP (NP (NNP Wellcome) (NNP PLC)) (, ,) (NP (DT a) (JJ major) (JJ British) (NN pharmaceutical) (NN maker)) (, ,)) (VP (VBZ sells) (NP (DT the) (NN drug)) (PP (IN under) (NP (NP (DT the) (NN name)) (NP (NNP Retrovir))))) (. .)))

(S1 (S (NP (DT A) (NNP Wellcome) (NN spokesman)) (VP (VBD declined) (S (VP (TO to) (VP (VB comment) (PP (IN on) (NP (NP (DT the) (NN discovery)) (PP (IN of) (NP (DT the) (NN antibody))) (PP (IN in) (NP (NNP Japan))))))))) (. .)))

(S1 (S (CC But) (NP (NP (NNP Andrew) (NNP Porter)) (, ,) (NP (NP (DT a) (NN drug-industry) (NN analyst)) (PP (IN at) (NP (NP (NNP Nikko) (NNPS Securities) (NNP Co.)) (PP (IN in) (NP (NNP London)))))) (, ,)) (VP (VBD said) (SBAR (IN if) (S (NP (DT the) (NN product)) (VP (VBD were) (S (VP (TO to) (VP (VB be) (VP (ADVP (RB successfully)) (VBN developed) (SBAR (S (NP (PRP it)) (VP (MD would) (VP (VB represent) (`` `) (NP (`` `) (NP (DT a) (JJ potential) (NN threat)) (PP (TO to) (NP (NP (DT the) (JJ long-term) (NN viability)) (PP (IN of) (NP (NNP Retrovir)))))))))))))))))) (. .)))

